Why Do HIV-1 and HIV-2 Use Different Pathways to Develop AZT Resistance?

Open Access

Peer-reviewed

Research Article

Paul L Boyer,

Affiliation HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland, United States of America
⨯
Stefan G Sarafianos,

Affiliation Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, United States of America
⨯
Patrick K Clark,

Affiliation Basic Research Program, SAIC-Frederick, Inc., NCI-Frederick, Frederick, Maryland, United States of America
⨯
Eddy Arnold,

Affiliation Center for Advanced Biotechnology and Medicine and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey, United States of America
⨯
Stephen H Hughes

*To whom correspondence should be addressed. E-mail: hughes@ncifcrf.gov

Affiliation HIV Drug Resistance Program, NCI-Frederick, Frederick, Maryland, United States of America
⨯

Reader Comments (0)

HIV-1
Is the Subject Area "HIV-1" applicable to this article?

Thanks for your feedback.
HIV-2
Is the Subject Area "HIV-2" applicable to this article?

Thanks for your feedback.
Polymerases
Is the Subject Area "Polymerases" applicable to this article?

Thanks for your feedback.
Nucleotides
Is the Subject Area "Nucleotides" applicable to this article?

Thanks for your feedback.
Insertion mutation
Is the Subject Area "Insertion mutation" applicable to this article?

Thanks for your feedback.
Microbial mutation
Is the Subject Area "Microbial mutation" applicable to this article?

Thanks for your feedback.
Hydrogen bonding
Is the Subject Area "Hydrogen bonding" applicable to this article?

Thanks for your feedback.
Polymerization
Is the Subject Area "Polymerization" applicable to this article?

Thanks for your feedback.